Mubadala Investment Company’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.74M Buy
+39,424
New +$4.55M 0.02% 31
2025
Q4
Sell
-48,613
Closed -$4.08M 84
2025
Q3
$4.08M Buy
48,613
+4,000
+9% +$329K 0.02% 25
2025
Q2
$3.53M Buy
+44,613
New +$3.55M 0.02% 31

Other funds holding MRK

Mubadala Investment Company's MRK Position: Q1 2026 in Review

Mubadala Investment Company opened a new position in Merck (MRK) in Q1 2026: 39,424 shares worth $4.74M. The stake represents 0.02% of the portfolio and ranks #31 among its holdings. This is a return to the name: Mubadala Investment Company previously reported a position in MRK as recently as Q3 2025.

Mubadala Investment Company first reported a position in MRK in Q2 2025 and has held it in 3 quarters since. 3,783 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Mubadala Investment Company held 39,424 shares of Merck worth $4.74M as of Q1 2026.
  • Merck was a new Mubadala Investment Company position in Q1 2026.
  • Merck made up 0.02% of Mubadala Investment Company's portfolio in Q1 2026, its #31 holding.
  • Mubadala Investment Company first reported a position in Merck in Q2 2025 and has held it in 3 quarters since.
  • 3,783 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Mubadala Investment Company's 13F filing for Q1 2026, filed 15 May 2026.